Hypodermic Needles Market Size

Hypodermic Needles Market size was valued at USD 4.39 billion in 2024 and is expected to cross USD 7.75 billion by the end of 2037, registering more than 4.6% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of hypodermic needles is estimated at USD 4.55 billion. The growth of the market can be attributed to the rising prevalence of chronic and infectious diseases such as Hepatitis B and Hepatitis C, along with the increasing number of diagnostic tests to treat such diseases. The Centers for Disease Control and Prevention estimates that 296 million people worldwide are infected with hepatitis B, while 58 million are infected with hepatitis C. According to the World Health Organization, global hepatitis C infections affect about 58 million people, and 1.5 million new infections occur each year. In addition, 1.5 million new cases of chronic hepatitis B are reported each year, with 296 million chronic hepatitis B infections in 2019. The increasing number of patients with chronic and infectious diseases has led to a surge in demand for hypodermic needles, as they are used to administer medications and vaccines to these patients. These needles are designed to deliver medication directly into the bloodstream, allowing for more efficient delivery of the medication and reducing the risk of infection.

In addition to these, factors that are believed to fuel the growth of hypodermic needles market include an increasing prevalence of chronic and Noncommunicable diseases (NCDs), a growing geriatric population, rising demand for injectable drugs, and increasing investments in healthcare infrastructure. The CDC reports that 6 out of 10 adults in the United States have at least one chronic disease. WHO estimates that NCDs account for 41 million deaths each year, representing 74% of all global deaths. With the rise in chronic NCDs, the need for medical treatments and procedures has also increased significantly. This has given rise to a higher demand for hypodermic needles market, as they are needed to administer medications and fluids to the patient.